Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2026-03-09 @ 2:22 AM
Study NCT ID:
NCT01617967
Status:
COMPLETED
Last Update Posted:
2024-04-19
First Post:
2012-06-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Tolerability of Patisiran (ALN-TTR02) in Transthyretin (TTR) Amyloidosis
Sponsor:
Alnylam Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ALN-TTR02-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None